OHLA Stock Drops Following $43 Million Setback in Kuwait Arbitration
Shares of OHLA, a Spanish construction company, experienced sharp declines of nearly 10% on the stock market after news broke that it must pay guarantees
PaxMedica Advances Drug Development for Autism and Rare Neurological Disorders
PaxMedica, Inc., a clinical-stage biopharmaceutical company based in Tarrytown, New York, is focused on developing innovative treatments for several challenging neurological conditions. Founded in 2018
Lufthansa Launches Its Own Travel Operator
Lufthansa Group is expanding its business by entering the package travel market. The airline conglomerate has established Eurowings Holidays GmbH, a new tour operator dedicated
REE Automotive: Pioneering the Future of Zero-Emission Vehicles
REE Automotive Ltd. is at the forefront of automotive technology, developing cutting-edge platforms that serve as the foundation for the next generation of zero-emission vehicles.
Rising Energy Costs: Will Gas Prices Climb Higher in 2025?
The annual energy cost analysis for German households reveals a significant financial burden. With electricity prices showing a slight decrease in 2024, gas costs surged.
OneMedNet Corp.: Innovating Clinical Imaging Solutions in Healthcare
OneMedNet Corp., a leading innovator in clinical imaging technology, is making significant strides in transforming the healthcare industry. The company specializes in developing advanced tools
Five Things Bitcoin Investors Should Know
Bitcoin’s meteoric rise has brought it tantalizingly close to the $100,000 mark. But what comes next? Should you jump in, hold on, or cash out?
Immunome, Inc.: A Leader in Antibody Therapeutics Development
Immunome, Inc., a trailblazing biopharmaceutical company, is dedicated to advancing the frontiers of antibody therapeutics. Founded on March 2, 2006, by Scott K. Dessain and
ABVC BioPharma, Inc.: A Promising Biotech Investment in Oncology and Mental Health Therapies
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company headquartered in Fremont, California, is emerging as a notable player in the biotech sector. With a focused portfolio
Candel Therapeutics’ Stock Gains Momentum as Viral Immunotherapy Shows Promise in Cancer Treatment
Candel Therapeutics, Inc., a biotechnology company in a late clinical stage, is making strides in the development and commercialization of viral immunotherapies aimed at treating
